DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on January 19, 2007; DOI: 10.1124/dmd.106.011478


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.011478v1
35/4/595    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evseenko, D. A
Right arrow Articles by Keelan, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evseenko, D. A
Right arrow Articles by Keelan, J. A


Received for publication June 13, 2006.
Revised January 14, 2007.
Accepted for publication January 16, 2007.

Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids and growth factors

Denis A Evseenko 1, James W. Paxton 2, Jeffrey A Keelan 1*

1 Liggins Institute, Auckland 2 The University of Auckland

* Address correspondence to: E-mail: j.keelan{at}auckland.ac.nz

Abstract

Placental ABC (ATP binding cassette) transporters protect placental and fetal tissues by effluxing xenobiotics and endogenous metabolites. We have investigated the effects of cytokines and survival/growth factors, implicated in various placental pathologies, on ABC transporter expression and function in primary placental trophoblast cells. Treatment of primary term trophoblasts in vitro with TNF-{alpha} or IL-1{beta} decreased mRNA and protein expression of apical transporters ABCB1/MDR1 (multidrug resistance gene product-1) and ABCG2/BCRP (breast cancer resistance protein) protein by 40-50% (P<0.05). In contrast, IL-6 increased mRNA and protein expression of the basolateral transporter ABCB4/MDR3 (P<0.05), while ABCC1/MRP1 expression was unaltered. Pretreatment of trophoblasts with TNF-{alpha} over 48 h resulted in significantly decreased BCRP efflux activity (increased mitoxantrone accumulation) with minimal changes in MDR1/3 activity. Epidermal growth factor (EGF) and insulin-like growth factor-II, on the other hand, significantly increased BCRP expression at the mRNA and protein level (P<0.05); EGF treatment also increased BCRP functional activity. Estradiol stimulated BCRP, MDR1 and MDR3 mRNA and protein expression by 40-60% and increased MDR1/3 functional activity (P<0.05). Progesterone had modest positive effects on MRP1 mRNA and MDR1 protein expression (P<0.05). In conclusion, this study demonstrates that pro-inflammatory cytokines, sex steroids and growth factors exert independent affects on expression of apical and basolateral placental ABC transporters in primary trophoblast. Such changes could alter placental drug disposition, increase fetal susceptibility to toxic xenobiotics and impact upon placental viability and function.


Key words: ABC transporters, drug transport, fetal toxicology, gene regulation, interleukins, p-glycoprotein, steroids, transporters


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
V. Petrovic, J.-H. Wang, and M. Piquette-Miller
Effect of Endotoxin on the Expression of Placental Drug Transporters and Glyburide Disposition in Pregnant Rats
Drug Metab. Dispos., September 1, 2008; 36(9): 1944 - 1950.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. A. Evseenko, P. Murthi, J. W. Paxton, G. Reid, B. S. Emerald, K. M. Mohankumar, P. E. Lobie, S. P. Brennecke, B. Kalionis, and J. A. Keelan
The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction
FASEB J, November 1, 2007; 21(13): 3592 - 3605.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.